Efficacy of coronavirus disease 2019 vaccines in patients with rheumatic diseases
Description
CONCLUSION: Patients receiving mycophenolate mofetil, rituximab, and steroids should be warned about the risk of a suboptimal vaccine response. If possible, vaccination strategies should be changed, and the dose modification of drugs should be made
